$10.34
0.333.30%
In chiusura: -
$10.40
0.060.58%
After hour: Nov 14, 4:08 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading NeoGenomics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni NeoGenomics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli NeoGenomics Inc addetti ai lavori?
A NeoGenomics Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 4.92K azioni del valore di $49.18K, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno ottobre 20, 2025, Alicia C Olivo, l'azienda EVP, GC & BUSINESS DEVELOPMENT sold 4.92K condivisioni per $10 ciascuna.
Statistiche sulla proprietà per NeoGenomics Inc
Numero di azioni emesse
129.388M
Azioni possedute dagli insider
7.098M
Percentuale posseduta dagli Insider
5.49%
Azioni possedute dagli investitori istituzionali
69.457M
Percentuale posseduta dagli investitori istituzionali
53.7%
Oct 20, 2025 | EVP, GC & BUSINESS DEVELOPMENT | -4.92K | $10.00 | -$49.18K | SELL | -10.26% | 43.02K | Oct 16 | ||
Aug 06, 2025 | CHIEF FINANCIAL OFFICER | 20.00K | $5.62 | $112.32K | BUY | 11.88% | 188.33K | Aug 06 | ||
Aug 06, 2025 | CHIEF EXECUTIVE OFFICER | 17.90K | $5.58 | $99.95K | BUY | 45.82% | 56.97K | Aug 06 | ||
May 28, 2025 | DIRECTOR | 5.00K | $7.60 | $38.00K | BUY | 15.75% | 36.76K | May 27 | ||
May 13, 2025 | PRES & CHIEF OPERATING OFFICER | 12.97K | $8.58 | $48.89K | BUY | 13.61% | 108.28K | May 11 - May 12 | ||
May 09, 2025 | DIRECTOR | 7.00K | $8.14 | $56.97K | BUY | 11.40% | 68.40K | May 09 | ||
May 09, 2025 | DIRECTOR | 4.00K | $7.78 | $31.12K | BUY | 11.08% | 40.09K | May 07 | ||
May 08, 2025 | CHIEF EXECUTIVE OFFICER | 18.90K | $7.88 | $148.92K | BUY | 166.73% | 30.24K | May 06 | ||
May 07, 2025 | DIRECTOR | 10.00K | $7.63 | $76.30K | BUY | 46.22% | 31.64K | May 05 | ||
May 07, 2025 | DIRECTOR | 4.51K | $7.75 | $34.98K | BUY | 39.79% | 15.85K | May 05 | ||
May 06, 2025 | CHIEF FINANCIAL OFFICER | 20.00K | $7.51 | $150.10K | BUY | 14.44% | 158.49K | May 02 | ||
Nov 19, 2024 | GENERAL COUNSEL | -5.17K | $15.36 | -$79.48K | SELL | -12.23% | 37.13K | Nov 15 | ||
Aug 19, 2024 | GENERAL COUNSEL | -1.04K | $16.05 | -$16.70K | SELL | -2.32% | 43.81K | Aug 15 | ||
May 17, 2024 | GENERAL COUNSEL | -1.05K | $15.74 | -$16.51K | SELL | -2.28% | 44.87K | May 15 | ||
Mar 06, 2024 | DIRECTOR | -6.11K | $15.97 | -$97.58K | SELL | -10.88% | 50.06K | Mar 04 | ||
Feb 20, 2024 | GENERAL COUNSEL | -2.59K | $14.96 | -$38.71K | SELL | -6.91% | 34.87K | Feb 15 | ||
Nov 20, 2023 | GENERAL COUNSEL | -2.67K | $18.39 | -$49.08K | SELL | -6.70% | 37.14K | Nov 17 | ||
Mar 09, 2022 | CHIEF FINANCIAL OFFICER | 1.79K | $12.90 | -$21.09K | SELL-OPTIONS | 1.76% | 103.52K | Mar 07 - Mar 08 | ||
Dec 23, 2021 | CHIEF FINANCIAL OFFICER | 3.15K | $22.04 | -$19.26K | SELL-OPTIONS | 23.30% | 16.69K | Dec 21 - Dec 22 | ||
Dec 06, 2021 | CHIEF EXECUTIVE OFFICER | 17.00K | $30.63 | $520.71K | BUY | 30.50% | 72.74K | Dec 06 | ||
Nov 29, 2021 | PRESIDENT, INFORMATICS | 0.00 | $22.58 | -$727.50K | SELL-OPTIONS | 0.00% | 15.47K | Nov 24 | ||
Nov 26, 2021 | CHIEF STRATEGY OFFICER | -100.00K | $36.96 | -$3.70M | SELL | -89.57% | 11.64K | Nov 23 - Nov 26 | ||
Jun 10, 2021 | DIRECTOR | 0.00 | $28.02 | -$557.39K | SELL-OPTIONS | 0.00% | 49.56K | Jun 08 | ||
Jun 04, 2021 | PRESIDENT, PHARMA SERVICES | -200.34K | $40.35 | -$8.08M | SELL | -50.45% | 196.77K | Jun 02 - Jun 03 | ||
May 27, 2021 | PRESIDENT, CLINICAL SERVICES | -3.65K | $25.56 | -$3.64M | SELL | -2.37% | 150.10K | May 25 | ||
Dec 15, 2020 | — | 88.80K | $30.23 | -$6.43K | OPTION EXERCISE | 757.91% | 100.52K | Dec 14 | ||
Dec 14, 2020 | — | -70.00K | $50.87 | -$3.56M | SELL | -6.12% | 1.07M | Dec 10 - Dec 14 | ||
Dec 11, 2020 | — | 0.00 | $29.01 | -$629.40K | OPTION EXERCISE | 0.00% | 24.98K | Dec 11 | ||
Dec 07, 2020 | DIRECTOR | -130.00K | $48.55 | -$6.31M | SELL | -10.21% | 1.14M | Dec 03 - Dec 07 | ||
Dec 07, 2020 | — | -24.68K | $47.88 | -$1.18M | SELL | -44.34% | 30.98K | Dec 04 | ||
Dec 04, 2020 | — | 0.00 | $27.41 | -$310.16K | OPTION EXERCISE | 0.00% | 12.06K | Dec 02 | ||
Nov 25, 2020 | — | 20.00K | $26.44 | -$4.77M | OPTION EXERCISE | 5.39% | 390.90K | Nov 24 - Nov 25 | ||
Nov 18, 2020 | — | -70.00K | $42.28 | -$2.96M | SELL | -51.17% | 66.80K | Nov 16 | ||
Nov 16, 2020 | — | 160.00K | $24.77 | -$10.52M | OPTION EXERCISE | 7.02% | 2.44M | Nov 12 - Nov 16 | ||
Nov 12, 2020 | — | 12.74K | $24.93 | $22.75K | OPTION EXERCISE | 28.96% | 56.73K | Nov 10 | ||
Sep 30, 2020 | — | -305.00K | $36.72 | -$10.28M | GIFT | -72.85% | 113.69K | Sep 28 - Sep 29 | ||
Sep 24, 2020 | — | -2.40K | $22.13 | -$301.46K | OPTION EXERCISE | -4.91% | 46.48K | Sep 22 - Sep 24 | ||
Sep 10, 2020 | — | -120.00K | $36.95 | -$4.43M | SELL | -7.07% | 1.58M | Sep 08 - Sep 10 | ||
Aug 10, 2020 | — | 17.50K | $23.25 | -$2.53M | OPTION EXERCISE | 4.95% | 370.90K | Aug 06 | ||
Aug 04, 2020 | — | 0.00 | $23.09 | -$682.98K | OPTION EXERCISE | 0.00% | 12.06K | Aug 03 | ||
Aug 04, 2020 | — | 0.00 | $23.38 | -$412.49K | OPTION EXERCISE | 0.00% | 24.98K | Aug 03 | ||
Aug 03, 2020 | — | 2.04K | $24.06 | -$2.28M | OPTION EXERCISE | 1.39% | 148.27K | Jul 30 | ||
Mar 05, 2020 | — | -1.93K | $19.45 | -$2.25M | OPTION EXERCISE | -1.25% | 151.64K | Mar 04 | ||
Mar 04, 2020 | — | -297.30K | $28.77 | -$8.55M | SELL | -56.84% | 225.71K | Mar 02 | ||
Dec 12, 2019 | CHIEF ACCOUNTING OFFICER | 0.00 | $17.20 | -$146.72K | SELL-OPTIONS | 0.00% | 2.27K | Dec 10 | ||
Nov 22, 2019 | DIRECTOR | -201.23K | $24.39 | -$4.91M | SELL | -45.02% | 245.71K | Nov 20 - Nov 21 | ||
Nov 21, 2019 | CHAIRMAN AND CEO | -187.50K | $24.08 | -$4.51M | SELL | -7.59% | 2.28M | Nov 19 | ||
Nov 18, 2019 | VP AND CHIEF CULTURE OFFICER | 0.00 | $15.49 | -$108.77K | SELL-OPTIONS | 0.00% | 22.86K | Nov 15 | ||
Nov 14, 2019 | PRESIDENT, PHARMA SERVICES | 25.00K | $15.15 | -$132.35K | SELL-OPTIONS | 8.31% | 325.83K | Nov 12 | ||
Nov 08, 2019 | PRESIDENT, PHARMA SERVICES | 0.00 | $14.98 | -$870.48K | SELL-OPTIONS | 0.00% | 300.83K | Nov 06 - Nov 07 | ||
Nov 04, 2019 | PRESIDENT, CLINICAL SERVICES | -10.11K | $15.51 | -$1.67M | SELL | -6.49% | 145.64K | Oct 31 - Nov 01 | ||
Sep 10, 2019 | DIRECTOR | -6.29K | $23.54 | -$68.11K | SELL | -6.30% | 93.53K | Sep 06 - Sep 10 | ||
Aug 30, 2019 | CHIEF STRATEGY OFFICER | 0.00 | $16.17 | -$294.27K | SELL-OPTIONS | 0.00% | 6.74K | Aug 28 | ||
Aug 30, 2019 | DIRECTOR | -40.74K | $25.02 | -$1.02M | SELL | -2.30% | 1.73M | Aug 28 - Aug 30 | ||
Aug 27, 2019 | DIRECTOR | -6.90K | $17.03 | -$312.85K | SELL | -4.89% | 134.10K | Aug 23 - Aug 26 | ||
Aug 27, 2019 | DIRECTOR | -53.00K | $25.41 | -$1.35M | SELL | -65.20% | 28.29K | Aug 23 - Aug 26 | ||
Aug 27, 2019 | DIRECTOR | -181.34K | $24.92 | -$4.52M | SELL | -9.30% | 1.77M | Aug 23 - Aug 27 | ||
May 09, 2019 | DIRECTOR | -150.00K | $22.41 | -$3.36M | SELL | -52.16% | 137.58K | May 07 - May 08 | ||
May 08, 2019 | CHIEF STRATEGY OFFICER | 0.00 | $15.53 | -$115.27K | SELL-OPTIONS | 0.00% | 6.74K | May 06 | ||
May 06, 2019 | VP AND CHIEF CULTURE OFFICER | 0.00 | $15.03 | -$462.77K | SELL-OPTIONS | 0.00% | 22.86K | May 02 - May 03 | ||
May 06, 2019 | PRESIDENT, CLINICAL SERVICES | 13.99K | $14.74 | -$1.66M | SELL-OPTIONS | 9.43% | 162.31K | May 02 | ||
May 06, 2019 | PRESIDENT, PHARMA SERVICES | 48.32K | $13.80 | -$2.51M | SELL-OPTIONS | 17.73% | 320.83K | May 02 - May 03 | ||
Mar 04, 2019 | VP AND CHIEF CULTURE OFFICER | 2.86K | $13.61 | -$511.24K | SELL-OPTIONS | 14.31% | 22.86K | Feb 28 - Mar 04 | ||
Feb 28, 2019 | EXECUTIVE VICE PRESIDENT | -299.87K | $18.90 | -$5.67M | SELL | -75.34% | 98.13K | Feb 26 - Feb 27 | ||
Feb 28, 2019 | PRESIDENT, CLINICAL SERVICES | 13.99K | $13.12 | -$2.07M | SELL-OPTIONS | 11.33% | 137.38K | Feb 26 - Feb 28 | ||
Feb 28, 2019 | CHIEF STRATEGY OFFICER | 0.00 | $13.38 | -$664.63K | SELL-OPTIONS | 0.00% | 0.00 | Feb 26 | ||
Feb 28, 2019 | DIRECTOR | 0.00 | $12.70 | -$234.36K | SELL-OPTIONS | 0.00% | 287.58K | Feb 26 | ||
Dec 26, 2018 | DIRECTOR | 26.00K | $11.60 | $301.60K | BUY | 33.39% | 103.87K | Dec 21 | ||
Dec 14, 2018 | — | -10.84M | $12.00 | -$130.02M | SELL | -100.00% | 0.00 | Dec 14 | ||
Nov 21, 2018 | DIRECTOR | -13.00K | $16.00 | -$207.94K | SELL | -25.37% | 38.23K | Nov 19 | ||
Nov 16, 2018 | DIRECTOR | 13.89K | $11.82 | $60.64K | SELL-OPTIONS | 37.19% | 51.23K | Nov 14 - Nov 15 | ||
Nov 14, 2018 | EXECUTIVE VICE PRESIDENT | -141.13K | $16.66 | -$2.35M | SELL | -37.55% | 234.75K | Nov 12 - Nov 14 | ||
Nov 13, 2018 | VP AND CHIEF CULTURE OFFICER | 0.00 | $10.83 | -$986.66K | SELL-OPTIONS | 0.00% | 20.00K | Nov 09 - Nov 12 | ||
Nov 13, 2018 | 10% OWNER | -4.16M | $16.75 | -$69.76M | SELL | -27.77% | 10.84M | Nov 09 | ||
Nov 13, 2018 | DIRECTOR | -66.01K | $17.03 | -$1.12M | SELL | -45.88% | 77.87K | Nov 09 | ||
Nov 13, 2018 | PRESIDENT, CLINICAL SERVICES | 83.51K | $10.90 | -$2.24M | SELL-OPTIONS | 209.37% | 123.39K | Nov 09 - Nov 12 | ||
Aug 01, 2018 | EXECUTIVE VICE PRESIDENT | -203.50K | $14.00 | -$2.85M | SELL | -7.97% | 2.35M | Jul 30 - Aug 01 | ||
Jun 29, 2018 | PRESIDENT, CLINICAL SERVICES | -12.94K | $13.12 | -$169.79K | SELL | -24.50% | 39.88K | Jun 29 | ||
Jun 26, 2018 | EXECUTIVE VICE PRESIDENT | -89.69K | $14.04 | -$1.26M | SELL | -3.40% | 2.55M | Jun 22 | ||
Jun 19, 2018 | EXECUTIVE VICE PRESIDENT | -160.31K | $13.32 | -$2.13M | SELL | -5.72% | 2.64M | Jun 15 - Jun 19 | ||
Jun 05, 2018 | EXECUTIVE VICE PRESIDENT | -223.64K | $12.12 | -$2.79M | SELL | -7.40% | 2.80M | Jun 01 | ||
May 31, 2018 | EXECUTIVE VICE PRESIDENT | -169.47K | $11.68 | -$1.98M | SELL | -5.29% | 3.03M | May 29 - May 31 | ||
May 31, 2018 | VP AND CHIEF CULTURE OFFICER | 0.00 | $8.22 | -$447.40K | SELL-OPTIONS | 0.00% | 13.32K | May 29 | ||
May 17, 2018 | VP AND CHIEF CULTURE OFFICER | 0.00 | $8.01 | -$83.92K | SELL-OPTIONS | 0.00% | 0.00 | May 15 | ||
May 10, 2018 | CIO | 0.00 | $8.53 | -$369.43K | SELL-OPTIONS | 0.00% | 9.00K | May 10 | ||
Jul 31, 2017 | DIRECTOR | 20.00K | $9.19 | $183.80K | BUY | 106.48% | 38.78K | Jul 27 | ||
Jun 26, 2017 | VP AND CHIEF CULTURE OFFICER | -10.72K | $8.49 | -$91.04K | SELL | -100.00% | 0.00 | Jun 22 | ||
Jun 06, 2017 | CIO | 0.00 | $6.04 | -$242.68K | SELL-OPTIONS | 0.00% | 9.00K | Jun 02 - Jun 05 | ||
May 30, 2017 | VP AND CHIEF CULTURE OFFICER | -3.33K | $7.50 | -$25.00K | SELL | -24.91% | 10.05K | May 26 | ||
Mar 22, 2017 | PRESIDENT, PHARMA SERVICES | -50.00K | $7.93 | -$396.65K | SELL | -75.81% | 15.95K | Mar 13 - Mar 20 | ||
Mar 17, 2017 | PRESIDENT, PHARMA SERVICES | 16.55K | $8.00 | $132.40K | s | 50.38% | 49.40K | Mar 13 | ||
Sep 27, 2016 | CHIEF MEDICAL OFFICER | -2.80K | $8.40 | -$23.52K | SELL | -2.21% | 124.18K | Sep 23 | ||
Sep 22, 2016 | CHIEF MEDICAL OFFICER | -105.30K | $8.20 | -$863.46K | SELL | -50.00% | 105.30K | Sep 20 | ||
Sep 13, 2016 | CHIEF MEDICAL OFFICER | -60.08K | $8.23 | -$494.12K | SELL | -18.16% | 270.68K | Sep 09 - Sep 12 | ||
Aug 23, 2016 | CHIEF MEDICAL OFFICER | 165.38K | $5.16 | -$2.14M | SELL-OPTIONS | 130.23% | 292.36K | Aug 19 | ||
May 27, 2016 | CHAIRMAN AND CEO | 0.00 | $5.21 | -$4.20M | SELL-OPTIONS | 0.00% | 3.35M | May 25 - May 27 | ||
May 20, 2016 | CIO | 0.00 | $6.64 | -$66.96K | SELL-OPTIONS | 0.00% | 9.00K | May 18 | ||
May 10, 2016 | CIO | 0.00 | $6.50 | -$51.60K | SELL-OPTIONS | 0.00% | 9.00K | May 09 | ||
May 03, 2016 | EXECUTIVE VP FINANCE | -177.75K | $8.21 | -$1.46M | SELL | -42.33% | 242.16K | May 02 - May 03 | ||
May 03, 2016 | CIO | 0.00 | $6.02 | -$470.25K | SELL-OPTIONS | 0.00% | 4.50K | Apr 29 | ||
Mar 14, 2016 | CHIEF FINANCIAL OFFICER | 68.00K | $4.14 | -$72.56K | SELL-OPTIONS | 48.20% | 209.09K | Mar 11 | ||
Mar 10, 2016 | CHAIRMAN AND CEO | 550.00K | $3.95 | -$2.39M | SELL-OPTIONS | 41.90% | 1.86M | Mar 08 - Mar 09 | ||
Mar 07, 2016 | DIRECTOR | 22.01K | $6.78 | $149.20K | BUY | 24.86% | 110.55K | Mar 03 - Mar 04 | ||
Mar 04, 2016 | DIRECTOR | 10.00K | $6.90 | $69.00K | BUY | 641.03% | 11.56K | Mar 03 | ||
Dec 23, 2015 | DIRECTOR | 9.50K | $8.21 | $78.00K | BUY | 187.75% | 14.56K | Dec 21 | ||
Dec 09, 2015 | DIRECTOR | 3.50K | $7.72 | $27.02K | BUY | 224.36% | 5.06K | Dec 07 | ||
Dec 04, 2015 | CHIEF OPERATING OFFICER | 6.55K | $7.75 | $50.76K | BUY | ∞ | 6.55K | Dec 03 | ||
Nov 27, 2015 | EXECUTIVE VP FINANCE | -410.00K | $8.09 | -$3.32M | SELL | -46.26% | 476.25K | Nov 25 - Nov 27 | ||
Nov 04, 2015 | DIRECTOR | 6.40K | $7.81 | $49.98K | BUY | 178.77% | 9.98K | Nov 02 | ||
Dec 22, 2014 | VICE PRESIDENT ANDGM PATHLOGIC | 0.00 | $2.78 | -$92.57K | SELL-OPTIONS | 0.00% | 0.00 | Dec 19 | ||
Dec 19, 2014 | VICE PRESIDENT ANDGM PATHLOGIC | 0.00 | $2.82 | -$173.62K | SELL-OPTIONS | 0.00% | 0.00 | Dec 18 | ||
Dec 08, 2014 | DIRECTOR | -11.80K | $4.50 | -$53.10K | SELL | -0.64% | 1.82M | Dec 04 | ||
Dec 01, 2014 | CHIEF FINANCIAL OFFICER | 70.00K | $2.91 | -$55.27K | SELL-OPTIONS | 98.47% | 141.09K | Nov 26 | ||
Nov 24, 2014 | DIRECTOR | -33.20K | $4.51 | -$149.71K | SELL | -1.78% | 1.83M | Nov 20 - Nov 21 | ||
Aug 27, 2014 | DIRECTOR | -300.00K | $3.00 | -$900.00K | SELL | -15.26% | 1.67M | Mar 05 | ||
May 27, 2014 | CHIEF SCIENCE OFFICER | 0.00 | $1.87 | -$324.16K | SELL-OPTIONS | 0.00% | 8.44K | May 22 | ||
May 21, 2014 | CHIEF SCIENCE OFFICER | -10.00K | $3.65 | -$36.53K | SELL | -54.23% | 8.44K | May 19 | ||
Mar 31, 2014 | CHIEF MEDICAL OFFICER | 14.49K | $3.51 | $50.85K | BUY | 29.58% | 63.49K | Mar 28 | ||
Dec 18, 2013 | CHIEF SCIENCE OFFICER | -646.00 | $3.74 | -$2.42K | SELL | -3.38% | 18.44K | Dec 17 | ||
Dec 17, 2013 | CHIEF SCIENCE OFFICER | -5.67K | $3.68 | -$20.88K | SELL | -22.91% | 19.09K | Dec 12 | ||
Dec 11, 2013 | CHIEF SCIENCE OFFICER | -20.10K | $3.70 | -$74.37K | SELL | -44.81% | 24.76K | Dec 10 - Dec 11 | ||
Dec 09, 2013 | CHIEF FINANCIAL OFFICER | 0.00 | $2.60 | -$42.20K | GRANT | 0.00% | 71.09K | Dec 09 | ||
Dec 06, 2013 | CHIEF SCIENCE OFFICER | -33.00K | $3.67 | -$121.10K | SELL | -42.38% | 44.86K | Dec 05 | ||
Dec 04, 2013 | CHIEF SCIENCE OFFICER | 67.85K | $1.96 | -$92.92K | GRANT | 678.54% | 77.85K | Dec 02 - Dec 03 | ||
Nov 26, 2013 | EXECUTIVE VP FINANCE | -112.97K | $3.58 | -$404.75K | SELL | -2.85% | 3.85M | Nov 22 - Nov 25 | ||
May 08, 2013 | CHIEF SCIENCE OFFICER | -2.50K | $3.60 | -$9.00K | SELL | -20.00% | 10.00K | May 02 | ||
May 01, 2013 | CHIEF SCIENCE OFFICER | 12.50K | $2.00 | -$127.95K | GRANT | ∞ | 12.50K | Apr 29 - May 01 | ||
May 01, 2013 | EXECUTIVE VP FINANCE | -100.00K | $3.71 | -$371.15K | SELL | -2.60% | 3.74M | Apr 29 - Apr 30 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.